Prospective analysis of health-related quality of life after surgery for spinal metastases by Koch, Jonathan E. J. et al.
European Spine Journal
 





Full Title: Prospective Analysis of Health Related Quality of Life after Surgery for Spinal
Metastases
Article Type: Original Article
Keywords: Health Related Quality of Life (HRQOL), spine metastases, spine surgery, Frankel
Score, EQ-5D, Oswestry Disability Index
Corresponding Author: Jonathan EJ Koch, M.D.
Queen's Medical Centre
Kfar-Saba, Israel UNITED KINGDOM
Corresponding Author Secondary
Information:
Corresponding Author's Institution: Queen's Medical Centre
Corresponding Author's Secondary
Institution:
First Author: Nasir A Quraishi, LLM, FRCS (Tr&Orth)
First Author Secondary Information:
Order of Authors: Nasir A Quraishi, LLM, FRCS (Tr&Orth)
Dritan Pasku, MD
Jonathan EJ Koch, M.D.
Georgios Arealis, MD, PhD, FRCS
Bronek M Boszczyk, PD Dr. med. Hon. Assoc. Prof.
Kimberley L Edwards, BSc (Hons); MMedSci; PhD; PGCAP; SFHEA
Order of Authors Secondary Information:
Funding Information:
Abstract: Purpose  Most spinal metastases are detected late and thus the impact of treatment on
the health related quality of life (HRQOL) is an important consideration. This study
investigated the HRQOL following surgery for spinal metastases.
Methods  Prospective study of patients operated for symptomatic spinal metastases, at
a single tertiary referral spine centre (2011-2013). Data was collected pre-operatively
and up to 2 years following surgery (if alive). The HRQOL assessment was performed
using recognised systems including the Frankel Score (neurological status), EQ-5D
and the Oswestry Disability Index.
Results  199 patients were studied (median age 65yrs, 43% (86) F; 57% (113) M). The
Frankel score improved significantly after surgery in 69 patients (35%), worsened in 17
(8%), with 20/39 patients regaining the ability to walk (51%). All the HRQOL scores
improved significantly following surgery.  The complication rate was 27%; median
survival 270 days, and 44 patients (22%) survived at 2 years.
Conclusions  This large prospective study showed that surgical treatment for spinal
metastases significantly improved the HRQOL.
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2. The HRQOL assessment in this study was performed using recognised 
systems including the Frankel Score (neurological status), EQ-5D and the 
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3. All the HRQOL scores improved significantly following surgery.  The 
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1. This is one of the largest studies of a prospective group of patients from a single 
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of patient-reported outcome and quality of life scores. 
2. The results show that surgical treatment for spinal metastases does significantly 
improve the health-related quality of life. 
3. Complication rates occurred in one quarter of all patients, and are comparable to 
other studies. The systemic nature of metastatic disease mean that patients are 
indeed more susceptible to post-operative complications during convalescence. 
Careful patient selection for surgery remains paramount, otherwise post-operative 
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Purpose Most spinal metastases are detected late and thus the impact of treatment on the health related 23 
quality of life (HRQOL) is an important consideration. This study investigated the HRQOL following 24 
surgery for spinal metastases.  25 
Methods Prospective study of patients operated for symptomatic spinal metastases, at a single tertiary 26 
referral spine centre (2011-2013). Data was collected pre-operatively and up to 2 years following 27 
surgery (if alive). The HRQOL assessment was performed using recognised systems including the 28 
Frankel Score (neurological status), EQ-5D and the Oswestry Disability Index.  29 
Results 199 patients were studied (median age 65yrs, 43% (86) F; 57% (113) M). The Frankel score 30 
improved significantly after surgery in 69 patients (35%), worsened in 17 (8%), with 20/39 patients 31 
regaining the ability to walk (51%). All the HRQOL scores improved significantly following surgery.  32 
The complication rate was 27%; median survival 270 days, and 44 patients (22%) survived at 2 years. 33 
Conclusions This large prospective study showed that surgical treatment for spinal metastases 34 
significantly improved the HRQOL.  35 
 36 
 37 
Keywords: Health Related Quality of Life (HRQOL), spine metastases, spine surgery, Frankel 38 










































































The role of surgery in the treatment of spinal metastasis has varied in its prominence over the past 45 
several decades. Historically, patients underwent non-instrumented decompression and tumor resection. 46 
However, comparison of un-instrumented surgery with radiotherapy showed no difference in outcomes 47 
[1]. Thus, radiation became a standard treatment in all patients with spinal metastases, with surgery 48 
being reserved for rare occasions. Advances in surgical techniques and instrumentation have resulted in 49 
improved outcomes and a broader spectrum of interventions available to patients, supporting the role of 50 
surgery in the treatment of spinal metastasis [1-3].  51 
 52 
The goals of surgery remain largely palliative and include the preservation or restoration of 53 
neurological function, mechanical stability and, rarely, oncologic control. Timely diagnosis and 54 
appropriate treatment selection are vital in optimizing the outcomes of treatment of metastatic spinal 55 
disease [4]. Indications for surgery in spinal metastases include spinal instability requiring stabilization 56 
with cement and/or instrumentation as well as urgent decompression with stabilization for epidural 57 
cord compression. 58 
Most spinal metastases are detected at later stages, when they are generally incurable. Thus, the impact 59 
of treatment on the HRQOL should be an even more important consideration in the choice of treatment. 60 
Studies of quality of life (assessed by patient recorded outcome measures) after surgery are only now 61 
starting to emerge [5, 6].  The purpose of this study was to investigate the HRQOL following surgery 62 
for spinal metastases. This was achieved by investigating the change in HRQOL (from pre-operatively 63 
to post-operatively and at final follow up) in a prospective cohort of patients following surgical 64 
intervention for spinal metastases using recognised HRQOL questionnaires. Our hypothesis was that 65 
surgery in patients with spinal metastases does improve the HRQOL.  66 
 67 
Methods 68 
This was a prospective study of consecutive patients who were admitted for surgery to treat 69 
symptomatic spinal metastases and metastatic spinal cord compression (MSCC) at a single tertiary 70 





































































years following surgery, whichever was sooner. Routine follow-up visits occurred at 6 weeks, 6 72 
months, 1 year and 2 years following surgery (or up to death if within 2 years). Indications for surgery 73 
included neurological deterioration and/or spinal pain due to mechanical instability from spinal 74 
metastases. Please see Figure 1 for a case illustration. Patients with primary bone tumours of the spine 75 
were excluded.  76 
 77 
The pre-operative data collected included patient demographics (age at surgery, gender), as well as the 78 
following: 79 
 - The revised Tokuhashi score [7] – an evaluation system for the prognosis of metastatic spinal 80 
tumours. The sum of the points of the following six items: general condition, number of extra-spinal 81 
bone metastases, number of metastases in the vertebral body, presence or absence of metastases to 82 
major internal organs, site of the primary lesion, and severity of palsy. Score 0-8; Survival <6 months, 83 
9-11; Survival 6-12 months, 12-15; Survival >1 year [7]. 84 
 85 
- The ASA (American Society of Anesthesiologists) score – a grading system for preoperative health of 86 
the surgical patients, based on five classes (1-5): 1. Completely healthy, fit patient, 2. Mild systemic 87 
disease. 3. Severe systemic disease that is not incapacitating. 4. Incapacitating disease that is a constant 88 
threat to life. 5. A moribund patient who is not expected to live 24 hour with or without surgery. 89 
metastatic tumor diagnosis, and surgical approach/type of operation.  90 
 91 
The outcome data included: 92 
 - Neurological status (Frankel Score) - a 5-point severity scale which is used to determine the severity 93 
of spinal-cord injuries. Patients are classified as complete (grade A), sensory only (grade B), motor 94 
useless (grade C), motor useful (grade D), or no neurological deficit/complete recovery (grade E) [8].  95 
 96 
 - The Karnosfky Performance Status  – this is a method of quantifying the functional status of cancer 97 






































































- The Visual Analogue Score (VAS) - this is a pain rating score that is based on self-reported measures 100 
of symptoms that are recorded with a mark placed at one point along the length of a line - “no pain” on 101 
the left end (0) of the scale and the “worst pain” on the right end of the scale (10) [11].  102 
 103 
- The EQ-5D score – this evaluates the quality of life across a wide range of disease areas. It comprises 104 
a short descriptive system questionnaire and a visual analogue scale. The descriptive questionnaire is 105 
measured by one question for each of the five dimensions: mobility, self-care, usual activities, 106 
pain/discomfort, and anxiety/depression. The score ranges from 0 for death to 1 for perfect health [12].  107 
 108 
- The Oswestry Disability Index (ODI) – this questionnaire contains 10 topics concerning intensity of 109 
pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, 110 
social life, sleep quality, and ability to travel. Each topic category comprises of 6 statements describing 111 
different potential scenarios in the patient's life with the first statement scored zero and indicating the 112 
least amount of disability and the last statement is scored 5 indicating most severe disability. The 113 
scores for all questions answered are summed (range 0 to 100), with zero is equated with no disability 114 
and 100 is the maximum disability possible [13].  115 
 116 
-The Short Form-36 (SF-36) - a 36-item patient-reported survey of patient health status. It consists of 117 
eight scaled scores: vitality, physical functioning, bodily pain, general health perceptions, physical role 118 
functioning, emotional role functioning, social role functioning, mental health. Each scale is directly 119 
transformed into a 0-100 scale. A score of zero is equivalent to maximum disability and a score of 100 120 
is equivalent to no disability [14]. Post-operative complications and survival were also noted. 121 
 122 
The data was analysed using SPSS version 24. All tests were two-sided; p values less than 0.05 were 123 
considered statistically significant. The median was used in all analysis (rather than mean), due to the 124 
skewed distribution of the data and not normally distributed (Shapiro-Wilk test). Thus, non-parametric 125 
tests were used (Wilcoxon signed-rank test for paired data; Mann Whitney for comparing continuous 126 
data between two different groups and chi-square tests for nominal data). Kaplan-Meier plots were 127 
produced to assess survival - patients were included from the date of surgery until 2 years following 128 







































































During the study period, 199 consecutive patients recruited into the study, from a total cohort of 248. 132 
Forty-nine patients were excluded (unwilling to participate/complete questionnaires (15); missed 133 
admissions (20); too unwell (14)).  134 
 135 
The median age of patients was 65 years (13-89): 43% (86) Female and 57% (113) Male. Blood cell 136 
dyscrasias (n = 39, 20%), prostate (n = 28, 14%), breast (n = 26,13%), GI (n = 25,13%) and 137 
renal/bladder (n = 24, 12%) primaries accounted for the majority of metastases (almost 80%). Pre- 138 
Operative Data is shown in Table 1. 139 
 140 
Table 1   Pre-Operative Data for all 199 Patients  141 
Age at surgery (median years, range) 65 (13-89) years 
Gender Male (No. %): Female 113: 86 
57%: 43% 
 
Revised Tokuhashi score (median score, range) 10 (3-15) 

































Adjuvant Treatment (No. %) 
 
 
Chemotherapy 52 (26%) 
Radiotherapy 59 (30%) 
Combined 34 (17%) 





































































Neurological Status 142 
In terms of neurology, 39 (20%) were unable to walk at the time of admission whilst post-operatively 143 
20 of these (51%) had regained the ability to walk; 19 remained non-ambulatory.  144 
The Frankel grid in Figure 2 shows the patients’ scores before (left hand data) and immediately after 145 
(right hand data) surgery.  In 113 patients (57%), the Frankel score remained unchanged after surgery; 146 
for 69 patients (35%) it improved significantly (p = 0.001) compared to 17 patients (8%) that worsened. 147 
 148 
Karnofsky Performance Status 149 
The median pre-operative Karnofsky physical functioning score was 46.9 (range 20-90) and this 150 
improved significantly to 56.5 (range 30- 90; p = 0.001) at 6 weeks. This improved for 127 patients 151 
(63.8%), remained unchanged for 26 (13%) and worsened for 46 (23.2%). In those patients that 152 
survived 2 years, this showed a tendency to improve over time (see Figure 3a).    153 
 154 
Visual Analogue Scores 155 
The median pre-operative VAS leg (or arm) pain score was 7 (range 0 - 10). This improved 156 
significantly to 2 at 6 weeks (range 0-8; p = 0.001) and this was sustained over the 2 years of follow up 157 
(p = 0.001) (see Figure 3b). The median pre-operative VAS back (or neck) pain score was 8 (range 0- 158 
10). This improved significantly to 3 at 6 weeks (range 0-8; p = 0.001) and this was also maintained 159 
over the 2 years of follow up (p = 0.001) (see Figure 3c).    160 
 161 
EQ-5D 162 
The median pre-operative EQ-5D score was 0.56 (range 0.516- 0.826). This improved significantly to 163 
0.67 (range 0.53-1; p = 0.001) at 6 weeks and was sustained over the 2 years of follow up, with the 164 
median score reaching a peak at 1 year post-operatively (see Figure 3d).    165 
 166 
Oswestry Disability Index 167 
The median pre-operative ODI score was 66 (range 12-86); this improved significantly to 52 (range 0- 168 
100; p = 0.001) at 6 weeks and this was sustained over the 2 years of follow up. This useful measure of 169 







































































The median pre-operative SF-36 score was 56 (range 36- 89) this improved significantly to 68 (range 173 
16- 98; p = 0.001) at 6 weeks and this was sustained over the 2 years of follow up (see Figure 3f).    174 
 175 
Complications 176 
Overall, there were 53 complications (27%) shown in Table 2. The most common of these were chest 177 
complications (n = 13, 7%) and infection (n = 12, 6%).  We had 4 patients who had more than one 178 
complication (2 patients had chest/respiratory complications and wound infection; 1 patient had wound 179 
infection and distal junction kyphosis; 1 patient with wound infection and significant intraoperative 180 
bleeding). The overall median survival was 270 (12- 2010) days. Using the Kaplan-Meier method the 181 
survival plot was created and is shown in Figure 4. In total, 44 patients (22%) survived at 2 years. 182 
Table 2   Complications in All Patients  183 
Type of complications No. (%) 
Chest 
- Chest Infection 
- Respiratory Failure 












- Excessive bleeding 
(>2L) 






- Urinary retention 
- Cardiac event 
- Post-operative 
confusion 
















Local disease progression 4 (2%) 
GI 
- GI bleed 




In-hospital death 2 (1%) 







































































This is one of the largest studies of a prospective group of patients from a single institution undergoing 186 
surgery for spinal metastases with comprehensive recordings of patient-reported outcome and quality 187 
of life scores. The results show that surgical treatment for spinal metastases does significantly improve 188 
the health-related quality of life.  189 
As Choi and others have previously highlighted, survival and complication rates had been the key 190 
parameters by which surgery for spinal metastases was measured with very little data on patient- 191 
reported outcome measures for surgery for spinal metastases [6]. More studies on quality of life scores 192 
are now emerging. Falicov et al., 2006 reported a small series of 85 patients who had improvements in 193 
pain, Health Utilities Index-3, EQ-5D, and European Organisation for Research and Treatment of 194 
Cancer (QLQ-C30) questionnaire up to one year after surgery [15]. This study has additionally shown 195 
these improvements occur in a range of functional outcome scores.  Furthermore, there were 39 196 
patients who were unable to walk at admission, and of these, half of whom regained the ability to walk 197 
after surgery. It was also found that the Karnofsky Performance Status improved progressively over 12 198 
months after surgery, as well as the other functional outcome scores (ODI, SF-36) reaching a peak at 1 199 
year.  200 
Complication rates occurred in one quarter of all patients, and are comparable to other studies [6]. The 201 
systemic nature of metastatic disease does, of course, mean that patients are indeed more susceptible to 202 
post-operative complications during convalescence. Careful patient selection for surgery remains 203 
paramount, otherwise post-operative complications may offset the intended benefits of surgery.  204 
Surgery does not aim to cure the disease, but to improve and maintain HRQOL, keeping patients out of 205 
hospital, walking and independent with little pain [16]. Improvements in surgical, medical and 206 
radiation techniques have significantly improved the quality and duration of life for patients with 207 
cancer [139]. Modern treatment of metastatic spinal tumours should involve a multi-disciplinary 208 
approach with Spinal Specialists, Oncologists, Radiologists as well as the Palliative/Rehabilitation 209 
Support Teams. Whilst all these specialist areas have improved their services, the goal of treatment of 210 





































































months, with 22% of patients surviving 2 years with better HRQOL scores than pre-operative for the 212 
duration.  213 
There have been a few studies looking at the ‘mean clinically significant difference’ with the quality of 214 
life and outcome scores utilized in this study [17-19]. Of those used, the ODI score although improving 215 
significantly, did not reach the mean clinically significant improvement criteria of 20% quoted in these 216 
studies. This is perhaps a limitation of the use of the ODI in this setting.  217 
‘Heterogeneity’ of different procedures for spinal metastases is clearly a limitation of this study and 218 
thus, collaborating with other centres (to increase patient numbers) is clearly important as this will 219 
allow a comparative analysis of different operations. It is worth noting that the study did not assess the 220 
outcome of patients who were treated without surgery, and therefore these findings cannot be 221 
generalised to all patients with metastatic spine tumours. The surgeon’s decision making on whether to 222 
go ahead with surgery or not, depends on (prognostic) decisions from the surgical and oncological 223 
teams including life expectancy and, of course, the wishes of the patient and discussion with their 224 
family. We can however say with some confidence, that in appropriately selected patients, surgery has 225 
provided significant improvements in pain, functional status and health related quality of life.  226 
 227 
Conclusion 228 
In summary, this study has reported on a large prospective series of patients undergoing surgery for 229 
spinal metastases. The results have shown that there were significant improvements following surgery 230 
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Figure Legends 1 
 2 
Figure 1   A 36-year-old gentleman who had undergone a thyroidectomy 2 years previously for 3 
follicular thyroid carcinoma presented with mechanical back pain with intact neurology (Frankel E). 4 
His MRI/CT scans showed isolated spinal metastases at L1 (Figures 1a-c). Sixteen hours after 5 
embolization, he underwent a spondylectomy and reconstruction (Figure 1d-e). The procedure was 6 
uneventful and he made an excellent recovery. Follow-up scans at 2 years (Figures 1f-g) confirmed that 7 
he was free of recurrence.  8 
 9 
 10 





Figure 2   The Frankel Grid for all Patients. In each square of the grid are two letters (A-E). The left 12 
hand letter represents the Frankel score before surgery and the right hand letter is the score immediately 13 
after surgery. The number of patients and percentage are plotted in each category. Thus, patients in the 14 
green boxes improved post-operatively, in the yellow boxes patients stayed the same neurologically, 15 
and those in the red boxes deteriorated.  16 
 17 
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Figure 3   HRQOL scores at 6 weeks, 6 months, 1 year and 2 years. a. Karnofsky Performance Status, 19 
b. VAS Leg Pain Scores, c. VAS Back Pain, d. EQ-5D Scores, e. ODI Scores, f. SF-36 Scores 20 
 21 
 22 
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